Metonitazene is a synthetic opioid compound structurally classified within the benzimidazole family. It is known for its extremely potent μ-opioid receptor agonism, which has made it a subject of increasing interest in receptor pharmacology, drug interaction modeling, and toxicological studies. Unlike traditional opioids such as morphine or fentanyl, Metonitazene features a unique structure that allows it to act with high potency, even at nanogram concentrations in certain assay models. It is strictly designated for in vitro and laboratory-based applications.

• Synthetic Origin: Metonitazene is not derived from naturally occurring opiates; it is fully synthetic, designed through molecular manipulation of benzimidazole frameworks to optimize opioid receptor binding.

• Receptor Targeting: It exhibits selective affinity for the μ-opioid receptor subtype, making it ideal for receptor-ligand interaction studies and drug efficacy modeling in opioid pharmacodynamics.

• Benzimidazole Classification: Its core structure places it in the nitazene class, a subgroup of synthetic opioids first developed in the 1950s but recently revisited for research due to their unique activity profiles.

• Extremely High Potency: Preclinical assays have shown Metonitazene to be significantly more potent than morphine or fentanyl in comparable μ-opioid receptor activation studies.

• Research-Only Use: Metonitazene is not approved for human or veterinary use and must only be handled in a laboratory by professionals trained in chemical safety protocols.

• Non-registered CAS: It currently lacks a formal CAS (Chemical Abstracts Service) registration, although it may be referenced in forensic and toxicological literature.

• Toxicological Relevance: Due to its high binding affinity, it is also being used in forensic toxicology calibration to understand synthetic opioid overdoses or environmental contamination.

The legality of Metonitazene is complex and varies significantly depending on the region or country. While it may not be explicitly listed as a controlled substance in some jurisdictions, it can still be regulated under analog or blanket scheduling laws. Researchers are strongly advised to verify local legislation before purchasing, possessing, or using Metonitazene.

• Unscheduled in Some Countries: Metonitazene is not globally scheduled, which means it may be legal to purchase for research purposes in countries that have not formally listed it.

• Controlled in the United States: As of recent DEA updates, Metonitazene has been placed under Schedule I in the U.S., making possession and sale without a license illegal, even for research.

• Analog Acts and Blanket Bans: In many regions, chemical analog laws can be used to prosecute possession or distribution of Metonitazene if it is structurally or functionally similar to controlled opioids.

• Forensic Use Exceptions: Licensed toxicology labs may be granted specific permissions to import or study Metonitazene for forensic calibration or overdose response research.

• Import Restrictions: Customs agencies in certain countries may intercept shipments of Metonitazene, even if it’s not explicitly scheduled, citing public health or safety concerns.

• Lab Registration Requirements: Some countries, like Germany or Australia, require prior authorization, licensing, or institutional registration before handling synthetic opioids, regardless of their scheduling status.

• Due Diligence is Essential: Buyers must perform regulatory due diligence before ordering Metonitazene and ensure full compliance with both national and local laws.

In scientific and preclinical research, Metonitazene has shown powerful central nervous system effects primarily mediated through the μ-opioid receptor. These effects are used to model drug response, dependency mechanisms, and overdose simulation in synthetic opioid studies.

• μ-Opioid Agonism: Metonitazene acts as a full agonist at the μ-opioid receptor, facilitating analgesia, euphoria, sedation, and respiratory depression—key features under investigation in opioid research.

• Receptor Binding Assays: In vitro testing confirms very high affinity and low dissociation constants, meaning Metonitazene remains bound to the receptor longer than many traditional opioids.

• Animal Model Research: Although not used clinically, studies in rodents (under ethical authorization) demonstrate that Metonitazene induces strong analgesic responses, often exceeding that of fentanyl in potency.

• Desensitization Studies: Its strong affinity makes it a candidate for studying opioid receptor downregulation, desensitization, and internalization, important in addiction and tolerance research.

• Respiratory Depression Models: Metonitazene is used to simulate respiratory suppression effects, helping researchers understand the risks associated with synthetic opioid toxicity.

• Structure-Activity Relationship (SAR): It provides a valuable framework for SAR studies, where minor structural changes are analyzed for corresponding changes in opioid activity.

• Toxicological Baselines: Its extreme potency makes it suitable for reference profiling in forensic toxicology, assisting in the detection of illicit analogs in biological specimens.

Proper storage of Metonitazene is critical to preserve its chemical stability, purity, and research value. The compound is sensitive to environmental conditions such as light, heat, and humidity, which can degrade its structure and compromise data integrity in laboratory settings.

• Temperature-Specific Storage: Store Metonitazene at –20°C or lower in a freezer specifically designated for chemical compounds. This helps prevent oxidation and decomposition over time.

• Desiccated Containers: Always seal the product in airtight vials with desiccants (such as silica gel packets) to control humidity exposure and prevent clumping or hydrolysis.

• Light-Resistant Packaging: The compound should be kept in amber or opaque containers that block UV and visible light, which may accelerate degradation.

• Avoid Frequent Thawing: Repeated freeze-thaw cycles can destabilize the molecular integrity of Metonitazene. Aliquoting into small, single-use containers is strongly recommended.

• Minimal Air Exposure: Open the container only in controlled environments such as fume hoods or glove boxes, and reseal immediately to minimize oxygen contact.

• Stable Shelf Life: When stored properly, Metonitazene retains its chemical fidelity for up to 24 months, but it should be periodically inspected for signs of degradation such as discoloration or off-odors.

• Inventory Rotation: Maintain strict inventory logs and use first-in, first-out (FIFO) practices to ensure the oldest batches are used first.

Handling Metonitazene requires extreme caution due to its ultra-potent opioid activity, which presents a high risk of accidental exposure, particularly via inhalation, ingestion, or transdermal absorption. Only trained laboratory professionals should work with this compound, following rigorous chemical safety protocols.

• Use of Personal Protective Equipment (PPE): Always wear nitrile gloves, lab coat, eye protection, and an N95 or P100 respirator mask when working with powder or solutions.

• Fume Hood Operations: Conduct all weighing, transferring, or dissolving procedures inside a certified fume hood or glove box to avoid airborne exposure or inhalation.

• Micro-Dosing Equipment: Because even microgram quantities can be biologically active, use high-precision microbalances and handle only the minimum required volume.

• No Direct Contact: Avoid any skin or mucosal contact. Even minor transdermal exposure can result in systemic absorption due to the compound’s lipophilicity.

• Secure Storage Access: Store in locked, access-restricted facilities with detailed logs of access and inventory for regulatory and safety compliance.

• Emergency Procedures: Have naloxone (opioid antagonist) and medical response protocols readily available in the event of accidental exposure or suspected overdose.

• Proper Disposal: Dispose of any unused material or contaminated equipment following hazardous chemical waste disposal protocols, not through regular lab waste streams.

Metonitazene can be shipped internationally by RC Plug, but buyers must be fully aware of the regulatory landscape and importation laws in their respective countries. While we facilitate discreet global delivery, the legal classification of Metonitazene may affect import clearance, depending on destination country policies and customs procedures.

• Discreet Global Shipping: We offer worldwide delivery in unmarked, tamper-resistant packaging, ensuring that your shipment arrives without attracting unnecessary attention or scrutiny.

• Customs Compatibility: Although RC Plug handles export logistics, import clearance is the buyer’s responsibility. If Metonitazene is restricted in your country, customs may delay or seize the shipment.

• Tracking and Delivery Guarantee: Every international order includes a tracking number, allowing real-time monitoring from dispatch to delivery. If your order is lost or intercepted, we provide reshipment or full refund, depending on the destination’s risk profile.

• Legal Risk Management: Customers are expected to verify the legal status of Metonitazene in their jurisdiction before ordering. We cannot provide legal advice but strongly recommend consultation with local authorities if unsure.

• Region-Specific Restrictions: Countries such as the U.S., Canada, and the U.K. may consider Metonitazene a controlled substance, and importing it without authorization can lead to legal consequences.

• Labeling and Documentation: We include internal labeling (not visible on outer packaging) and can supply CoA or MSDS upon request to support legitimate research import claims.

• Support with Customs Documentation: If your country requires specific customs declarations or research credentials, our customer service team can assist by providing invoice clarification or compliance documentation.

Though both Metonitazene and fentanyl are classified as synthetic opioids, they are structurally and pharmacologically distinct. These differences have critical implications for research, especially in studies focusing on structure-activity relationships (SAR), binding affinity, and overdose risk modeling.

• Chemical Structure: Metonitazene belongs to the benzimidazole class, while fentanyl is derived from anilidopiperidine compounds. This structural divergence results in unique receptor interactions and metabolic profiles.

• Receptor Binding Profiles: Both act as full μ-opioid receptor agonists, but Metonitazene often demonstrates higher binding affinity in in vitro studies, suggesting stronger or longer-lasting receptor occupancy.

• Potency: Preclinical evidence shows Metonitazene is significantly more potent than fentanyl, with active concentrations effective in the low nanogram or microgram range.

• Duration of Action: Metonitazene’s extended half-life may result in longer biological activity in comparison to fentanyl, making it useful for modeling chronic or sustained opioid effects.

• Legal Status: Fentanyl is uniformly classified as a Schedule II substance, whereas Metonitazene remains unclassified or Schedule I in many regions. This makes the latter more accessible for certain types of academic research.

• Toxicological Applications: Due to the prevalence of fentanyl in overdose cases, Metonitazene is often used as a reference analog to distinguish structurally different opioids in forensic toxicology.

• Solubility and Formulation: Fentanyl exhibits higher aqueous solubility than Metonitazene, influencing formulation methods in research, especially when preparing injectable or solution-based assays.

Analytical validation of Metonitazene ensures purity, identity, and structural integrity, which is vital for reproducible and reliable research outcomes. RC Plug uses industry-standard and advanced analytical technologies to provide comprehensive documentation with each batch.

• High-Performance Liquid Chromatography (HPLC): HPLC is used to quantify purity by isolating and measuring Metonitazene from any potential impurities or byproducts. Our products typically exceed 98% purity.

• Gas Chromatography-Mass Spectrometry (GC-MS): GC-MS allows for precise structural analysis by identifying molecular weight and fragmentation patterns, ensuring the compound matches the expected profile.

• Fourier-Transform Infrared Spectroscopy (FTIR): FTIR is employed to confirm functional groups and bonding structures, providing a molecular fingerprint unique to Metonitazene.

• Nuclear Magnetic Resonance (NMR) Spectroscopy: Advanced labs may use NMR for 3D structural confirmation, verifying proton and carbon environments in the benzimidazole backbone.

• Melting Point Analysis: This basic technique helps assess batch consistency and integrity, as each chemical has a unique melting range.

• Elemental Analysis: Confirms the ratio of constituent atoms (C, H, N, O) to ensure it matches theoretical expectations for C23H30N4O2.

• Certificate of Analysis (CoA): Each batch sold by RC Plug includes or can be accompanied by a CoA detailing all analytical results, validated by independent third-party labs.

Metonitazene is an ultra-potent compound, and only extremely small quantities are required for receptor binding studies or in vitro assays. It is never used for human or in vivo animal administration outside of licensed facilities with ethical approval.

• Microgram-Level Precision: Research doses typically fall within the 1–100 microgram range, with high receptor activation observed at even the lower end of that spectrum.

• Not for Human Use: There is no medically approved or recommended dosage for human use, and any suggestion of human experimentation is illegal and dangerous.

• Cell-Based Assays: In vitro applications often use nanomolar concentrations to assess opioid receptor activity without inducing cytotoxicity.

• Binding Affinity Studies: For μ-opioid binding assays, researchers often prepare serial dilutions starting from ~10⁻⁶ M down to 10⁻¹² M for EC50/IC50 calculations.

• Use of Microbalances: Due to potency, it is essential to use analytical balances with readability down to 0.001 mg or better to avoid overdose in lab settings.

• Aliquoting for Accuracy: Bulk powder is often dissolved in solvent and aliquoted into smaller doses to avoid measurement error during daily research operations.

• No Prescribed Dose Range: Since it’s a research chemical, there are no pharmacokinetic dose-response curves approved by regulatory agencies.

Metonitazene is one of several synthetic opioids in the nitazene family, but it stands out due to its potency, structural efficiency, and long receptor engagement. Compared to analogs like Isotonitazene and Etonitazepyne, Metonitazene exhibits superior performance in several research-critical areas.

• Higher Receptor Potency: Among the nitazenes, Metonitazene is regarded as one of the most potent, often exceeding the receptor binding strength of Isotonitazene in μ-opioid assays.

• Structural Optimization: Metonitazene’s isopropylphenyl and diethylamino side chains contribute to its high lipophilicity and increased bio-receptor interaction.

• Duration of Action: In receptor kinetic models, Metonitazene has a longer half-life than many other nitazenes, making it more suitable for long-term binding studies.

• Solubility Profile: Its solubility in DMSO and ethanol is similar to other nitazenes, though slightly less stable in aqueous conditions than Etonitazepyne.

• Regulatory Status: While some nitazenes like Isotonitazene are widely scheduled, Metonitazene remains uncontrolled or only recently listed in some jurisdictions, making it more accessible for certain labs.

• SAR Relevance: Metonitazene provides a robust platform for Structure-Activity Relationship (SAR) experiments, especially for researchers analyzing opioid agonist profiles.

• Reference Material Use: It is increasingly employed as a benchmark compound for studying newer, less-characterized nitazenes due to its well-documented effects and activity levels.

Metonitazene is a chemically sensitive compound, and room temperature storage is not ideal for maintaining its potency, purity, or structural integrity. While brief exposure during handling may not cause immediate degradation, long-term storage outside of controlled conditions will compromise research reliability. Understanding its physical stability is crucial for labs managing sensitive analytical substances.

• Degradation Risk: At room temperature (~20–25°C), Metonitazene can begin to degrade slowly due to oxidative or hydrolytic processes, especially in the presence of light or moisture.

• Recommended Storage Conditions: For maximum stability, it should be stored at –20°C or lower in sealed, moisture-resistant containers to prevent decomposition.

• Short-Term Exposure: Temporary exposure to room temperature (for example, during sample preparation or weighing) is acceptable for less than 30 minutes, provided the compound is promptly resealed.

• Visual Indicators of Breakdown: Changes in color (from off-white to yellowish), clumping, or odor indicate potential chemical breakdown or contamination, warranting disposal or retesting.

• Stability in Solution: When dissolved in solvents such as ethanol or DMSO, Metonitazene must be used immediately or stored at –20°C in sealed vials, as solutions are even more vulnerable to degradation.

• Impact on Research Validity: Using degraded material can compromise the accuracy of receptor binding assays or toxicological modeling, leading to flawed data or invalid conclusions.

• Packaging Influence: Storage in light-blocking amber vials with desiccants can extend room-temperature shelf life marginally, but should not be relied on for long-term preservation.

Metonitazene is increasingly recognized as a valuable reference standard in forensic toxicology, particularly in the identification and quantification of emerging synthetic opioids in biological samples. As its presence has been linked to overdose cases in some regions, forensic laboratories are integrating Metonitazene into their analytical frameworks.

• Reference Calibration: Metonitazene can be used as a standard compound to calibrate GC-MS and LC-MS/MS systems, allowing labs to accurately detect it and its analogs in blood, urine, or tissue.

• Toxicological Relevance: Its inclusion in forensic screening panels is critical, as some overdose deaths in recent years have involved Metonitazene or closely related nitazenes.

• Metabolite Identification: Forensic labs also study its metabolic breakdown products, which may appear in toxicology reports even when the parent compound is absent.

• Low Detection Limits: Due to its extreme potency, analytical systems must be highly sensitive (nanogram-level detection) to identify trace amounts relevant to postmortem or clinical toxicology.

• Standardization Support: RC Plug can provide Certificates of Analysis (CoA) and Material Safety Data Sheets (MSDS) to support admissibility and method validation in legal cases.

• Tissue Affinity Research: Advanced forensic research includes studying how Metonitazene distributes in fat, brain, or hepatic tissue, which assists in autopsy interpretations.

• Chain of Custody Requirements: When used in forensic cases, Metonitazene should be handled in accordance with strict documentation and traceability protocols, often under DEA/forensic regulation standards.

Metonitazene has not undergone formal clinical testing for addiction potential in humans, but its pharmacological similarity to high-potency opioids strongly suggests that it carries a high abuse and dependence risk. For this reason, it must be handled only by trained personnel in licensed research settings and never exposed to non-laboratory environments.

• High μ-Opioid Agonism: Metonitazene acts as a full μ-opioid receptor agonist, similar to heroin, fentanyl, and oxycodone—compounds well-known for their addictive potential.

• Tolerance Development: In opioid pharmacology, frequent exposure to potent agonists can lead to rapid tolerance, requiring progressively higher doses to achieve the same effect. This is also expected with Metonitazene.

• Dependence Mechanisms: Animal model data suggest that prolonged μ-opioid receptor activation can induce physical dependence, characterized by withdrawal symptoms if the substance is removed.

• Potential for Misuse: Although not approved for clinical use, its potency and euphoria-inducing properties (if misused) make it a significant risk in illicit markets and uncontrolled environments.

• Lack of Human Data: No controlled human trials exist, but anecdotal and toxicological evidence implies a very high risk of addiction if consumed, even in minuscule doses.

• Reinforcement Behavior in Animals: Studies show self-administration of Metonitazene in rodent models, indicating reinforcing properties associated with substance dependence.

• Research Restrictions: Given this risk, access and use of Metonitazene should always be confined to authorized research professionals, and storage must follow strict security protocols.

The shelf life of Metonitazene, like many synthetic opioids, is primarily determined by storage conditions, packaging, and exposure to environmental stressors. When handled correctly, Metonitazene can maintain its integrity and research-grade quality for up to two years.

• Optimal Shelf Life: When stored at –20°C in sealed, light-resistant containers, the compound can maintain ≥98% purity for 24 months or longer without significant degradation.

• Accelerated Breakdown Factors: Exposure to heat, moisture, oxygen, or light can rapidly reduce shelf life. Even short-term exposure may result in chemical transformation or loss of efficacy.

• Batch-Specific Expiry Dates: RC Plug provides a clearly labeled expiration date for each batch based on analytical data and stability studies.

• Retesting Recommendation: For samples stored for extended periods, it is advisable to retest the compound via HPLC or FTIR before using in critical research.

• Visual Signs of Degradation: Changes in color (darkening), texture (clumping or stickiness), or odor may signal the compound has surpassed its usable life.

• Aliquoting and Stability: Dividing bulk quantities into small, sealed aliquots helps reduce repeated exposure and preserves shelf life across multi-use studies.

• Freeze-Thaw Cycle Limitation: Repeated thawing and freezing destabilizes chemical bonds. Best practice involves removing only the amount needed per experiment.

Yes. Every batch of Metonitazene we distribute undergoes rigorous, multi-step testing protocols to confirm identity, purity, and safety for research use. We partner with accredited third-party laboratories to ensure that each shipment meets professional analytical standards.

• Third-Party Lab Verification: We work with independent certified labs to test each production batch for accuracy, ensuring results are unbiased and repeatable.

• High-Purity Guarantee: Our standard is ≥98% purity, verified via HPLC or GC-MS, and stated clearly on the Certificate of Analysis accompanying the order.

• Consistency Between Batches: In addition to content purity, we verify that retention time, mass spectrometry fragmentation, and FTIR fingerprinting match reference specifications to ensure inter-batch consistency.

• Heavy Metal & Contaminant Screening: Metonitazene batches are tested for toxic impurities or heavy metals, ensuring no interfering substances compromise research or safety.

• Pre-Packaging Inspection: All compounds are inspected and quality-verified immediately before packaging, ensuring the material you receive is fresh and stable.

• Documentation Transparency: We include or provide upon request a CoA, MSDS, and analytical summary, confirming compliance with international lab safety expectations.

• Batch Control Numbering: Every package is labeled with a unique batch number, allowing traceability and quality assurance tracking for any inquiry or publication.

Yes, at RC Plug, we offer a 30-day full refund or product replacement guarantee to ensure your complete satisfaction. Whether your order was damaged in transit, failed to meet quality standards, or encountered delivery issues, we are committed to resolving the matter swiftly and professionally.

• 30-Day Guarantee: You may request a full refund or replacement within 30 days of receiving your order, as long as the product remains unopened and unused.

• Eligibility Requirements: Returns are accepted for issues involving purity discrepancies, damage during transit, incorrect items shipped, or failure to arrive (with proof of loss via tracking).

• No-Hassle Process: We make the return process straightforward. Simply contact our support team with your order number, and we’ll guide you through the next steps.

• Fast Resolution: Once we receive your return or investigate your claim, we issue refunds or replacements within 2–5 business days, depending on your preferred resolution.

• Refund Methods: Refunds are issued via your original payment method, whether Bitcoin, bank transfer, Zelle, CashApp, or Western Union.

• Discreet Packaging Preservation: Returned products must be in their original discreet packaging, untampered and intact, to be eligible for full reimbursement.

• Customer-Centered Policy: We prioritize scientific and logistical reliability, and our policy reflects our commitment to ensuring researchers are never disadvantaged.